Tel: +86 (0)571 8102-5280
Email: sales@molcore.com
Language :
English
中文版
日本語
Search
Home
About Us
CRO&CDMO
Services
Custom Synthesis
Process development
IP & Quality
Facility
R&D Center
Manufacturing
Products
Contact Us
Name Index L
Home
Sitemap
Name Index L
Recently searched keywords
3125-64-2
,
138022-01-2
,
34649-02-0
,
813461-34-6
,
1261576-39-9
,
7073-93-0
,
1185-57-5
,
1220036-74-7
,
69359-47-3
,
494773-67-0
,
926276-19-9
,
922723-25-9
,
1315629-79-8
,
1338669-69-4
,
219143-04-1
,
2612-27-3
,
80793-25-5
,
1630906-37-4
,
1891914-73-0
,
161485-82-1
,
21358-24-7
,
29290-42-4
,
4664-55-5
,
1820609-04-8
,
621-56-7
,
171046-94-9
,
351369-58-9
,
17680-55-6
,
13451-79-1
,
5267-87-8
,
55750-48-6
,
618446-32-5
,
5926-55-6
,
5955-74-8
,
274676-47-0
,
850375-10-9
,
14180-51-9
,
898782-50-8
,
37682-72-7
,
1171758-58-9
,
2162-74-5
,
64834-00-0
,
1246549-95-0
,
540750-32-1
,
1638761-21-3
,
1415559-71-5
,
61689-43-8
,
855874-32-7
,
50920-46-2
,
4643-27-0
,
916343-43-6
,
10252-66-1
,
1416439-67-2
,
2270872-91-6
,
60750-37-0
,
85684-61-3
,
59032-71-2
,
1806327-54-7
,
27612-67-5
,
861334-81-8
Products Sitemap
Cas Index
1
2
3
4
5
6
7
8
9
Name Index
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name Index L
SKU
Chemical Name
Molecular Formula
MC807357
417714-14-8 | Lenvatinib Impurity g
MC807356
1533519-98-0 | Lesinurad Impurity 7
MC807355
1533519-93-5 | Lesinurad Impurity B
MC807352
1446263-38-2 | Linagliptin iMpurity E
MC807350
1646355-34-1 | Linagliptin impurity R
MC807335
30508-27-1 | Licoricidin
MC807324
956136-95-1 | Pradigastat
MC807226
894002-50-7 | LDN 212320
MC807205
862901-87-9 | LT175
MC807106
58471-53-7 | L-Aspartic acid, L-a-aspartyl-
C8H12N2O7
MC807095
554-13-2 | Lithium carbonate
CLi2O3
MC807023
213476-12-1 | Lansoprazole n-oxide
MC806884
117678-38-3 | Levofloxacin n-oxide
MC806849
1006062-28-7 | Losartan Impurity D
C41H37ClN6O
MC806658
880762-37-8 | L-Cysteine,N-[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]-S-(triphenylmethyl)-
MC806615
1642303-38-5 | Lenrispodun phosphate
C29H29FN7O5P
MC806080
1185240-53-2 | Lumefantrine-d18
MC805956
121250-47-3 | LinoleicAcid
C18H32O2
MC805807
1246820-62-1 | Losartan-d4 Carboxylic Acid
MC805781
1256364-24-5 | Lithium triisopropyl 2-(6-methylpyridyl)borate
C15H27BLiNO3
MC805681
1262036-49-6 | LY2886721 HCl
MC805348
1393822-91-7 | Lithium (5-cyano-2-pyridyl)-trihydroxy-boranuide
C6H6BLiN2O3
MC805347
1393-92-6 | Litmus
MC805217
1454682-72-4 | LY-3009120(DP-4978)
C23H29FN6O
MC804718
186204-32-0 | Lurasidone Metabolite 14283 HCl
MC804717
186204-33-1 | Lurasidone Inactive Metabolite 14326
MC804407
226578-51-4 | Levofloxacin mesylate
C19H24FN3O7S
MC804244
25721-92-0 | Lanthanum acetate sesquihydrate
C12H24La2O15
MC804112
2922-61-4 | Lithium 2-oxopropanoate
C3H3LiO3
MC802461
74639-14-8 | Liquiritin apioside
Prev
6
7
8
9
10
11
12
13
Next
© Copyright 2015-2024 Hangzhou MolCore BioPharmatech Co.,Ltd. All rights reserved.